from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3068c/pgmA

LFCtreatmentdescriptionclass of inhibitor

-0.929

Amikacinug/mL Amikacintranslation

-0.472

Cap5-10ug/mL Capreomycintranslation

-0.680

Rox10-50 ug/mL Roxithromycintranslation

-0.614

SM2-5 ug/mL Streptomycintranslation

-1.251

Tet5-10 ug/mL Tetracyclinetranslation

-0.084

Rif0.2-5ug/mL Rifampicintranscription

-0.104

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.880

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.301

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.951

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.466

Clofazimine10-13 ug/mL Clofaziminerespiration

1.276

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.732

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.261

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.497

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.304

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.518

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.412

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.444

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.588

KCN5-20 ug/mL Potassium cyaniderespiration

1.828

NaN30.2-2 mM Sodium aziderespiration

0.389

Nigericin50 uM Nigericinrespiration

-0.082

TRC10-150 ug/mL Triclosanrespiration

2.523

TRZ10-25 ug/mL Thioridazinerespiration

-1.730

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.620

menadione6-10 ug/mL Menadionerespiration

-0.282

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.436

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.522

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.615

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.325

NRP_1Non-replicating persistence stage 1dosRassociated

-0.404

Amp0.2mg/mL AmpicillincellWall

0.242

Cephalexin20-100 ug/mL CephalexincellWall

-0.300

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.763

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.357

EMB10-20 ug/mL EthambutolcellWall

-0.484

Eta12-40 ug/mL EthionamidecellWall

-0.675

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.325

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.724

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.775

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.423

BZA0.12 mg/mL BenzamidearomaticAmides

-0.085

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.007

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.618

H2O24 mM hydrogen peroxideDNAdamaging

0.245

Levo10 ug/mL LevofloxacinDNAdamaging

-0.001

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.055

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.413

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.297

UVUV-irradiationDNAdamaging

1.269

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.226

Antimycin12.5-50 ug/mL Antimycin A?

0.005

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.233

PA_110-50 ug/mL Antitubercular compound PA-1?

0.070

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.206

PA8240.2-2 ug/mL PA-824?

-0.331

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.914

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.101

Verapamil50 uM Verapamil?

-0.022

mercaptoethanol2 mM 2-Mercaptoethanol?

0.384

methoxatin10-20 ug/mL Methoxatin?